Position in ASND
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$31,762,351
-$18,098,959 QoQ
Shares Held
119,085
-45.4% QoQ
Ownership
0.182%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#61
of 308 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ASND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026TD Asset Management Inc holds $1,129,937,988 across 119 Biotechnology names. ASND ranks #7 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
259,317 | $161,694,522 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
207,960 | $103,299,970 | |
| 3 | HALO |
Halozyme Therapeutics, Inc.
|
1,115,730 | $87,328,187 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
233,696 | $70,349,506 | |
| 5 | CYTK |
Cytokinetics Inc
|
385,130 | $32,809,224 | |
| 6 | RPRX |
Royalty Pharma plc
|
567,497 | $31,819,556 | |
| 7 | ASND |
Ascendis Pharma A/S
This page
|
119,085 | $31,762,351 | |
| 8 | KYMR |
Kymera Therapeutics, Inc.
|
272,900 | $31,293,443 |
All Filings in ASND
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $31,762,351 | 119,085 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $49,861,310 | 217,992 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $49,900,718 | 234,012 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $58,916,548 | 296,346 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $50,414,734 | 292,090 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $53,520,765 | 343,390 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $46,759,890 | 339,652 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $37,793,944 | 253,124 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $13,630,635 | 99,946 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $35,807,637 | 236,870 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $30,804,599 | 244,578 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $25,035,590 | 267,360 | Shares | Sole | 2023-10-27 | |
| 2023-06-30 | $22,736,883 | 254,755 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $25,324,720 | 236,194 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $23,974,119 | 196,300 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $13,589,016 | 131,600 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $9,944,024 | 106,971 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $13,354,511 | 113,791 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $15,011,260 | 111,583 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $14,446,312 | 90,635 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $10,105,802 | 76,821 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $13,531,755 | 104,995 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $21,144,535 | 126,781 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $17,864,854 | 115,765 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $17,630,419 | 119,205 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $12,883,034 | 114,404 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||